Merck’s first quarter results drew a positive market reaction, reflecting operational resilience despite a 1.6% ...

Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment ...

There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

Merck launches AI-powered search, offering patients fast, trusted answers from its widely used medical manuals and resources.

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance ...

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the ...

Merck & Co., Inc. (NYSE:MRK) is one of the best dividend stocks for dependable dividend growth. The company is not only ...

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

South Korea's Dongjin Semichem has licensed its OLED material patents to major companies, including Germany's Merck and Japan ...

Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...